Stacy Kuebelbeck Paulsen | News Writer | CIDRAP NewsOct 30, 2020The drug reduced viral loads by a factor of 3.4 at one dosage tested.
Eli Lilly’s COVID-19 antibody treatment shows promise
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Teen vaccination cut COVID-19 cases by 37% in California, new data show
- US study shows post-COVID rebound in inappropriate antibiotic prescribing
- Data: Optimal initiation of Paxlovid in hospitalized COVID patients is 3 to 5 days
- National COVID-19 guidelines vary widely, often promote ineffective treatments